TUSTIN, Calif., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient ...
Avid’s been through a tough year, with an unexpected change of CEO. But that hasn’t stopped the pace of development. We report from the Avid NAB Press Conference. Avid’s press conference is vast, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results